Joseph Aslan: mPTP Inhibition Targets Platelet Procoagulant Activity and Thrombosis
Joseph Aslan, Associate Professor at Oregon Health and Science University, shared a post on X about recent article he and his colleagues co-authored, published in Blood Journal, adding:
“Happy to share our First Edition Blood Portfolio paper from yiiihengzhang and OHSUCardio, OHSUChemBio, OHSU BME
team: mPTP inhibitors selectively suppress platelet procoagulant activity and thrombosis while preserving key platelet functions.”
Title: Inhibition of mitochondrial permeability transition selectively suppresses thrombogenic platelet procoagulant activity
Authors: Yiheng Zhang, Jordan Sandler, Osamede Clinton Owegie, Xu Zhang, Vrishank Shivaprakash, Jack Kurth, Yong Sun, Mayu Morita, Raquel Mote, Neva Scott, Gavin Hutchison, Eliana Choi, Helena Ventosa-Capell, Jiaqing Pang, Cristina Puy, Yabing Chen, Terry Morgan, Owen JT McCarty, Moua Yang, Michael Cohen, Joseph E Aslan
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 7, 2026, 03:00Sandeep Kumar: A Second Chance for a Child with Fanconi Anemia
-
Oct 7, 2026, 02:41Kemal Karaagac: Optimising DOAC Resumption After Major Bleeding in Atrial Fibrillation
-
Oct 7, 2026, 02:07Manuel Monreal: ECG Improves Risk Stratification in Acute Pulmonary Embolism
-
Oct 6, 2026, 22:43Alessandra Bosch: Pediatric GTH Opens with Regional Experts Convening on Pediatric Hemostasis and Thrombosis
-
Oct 6, 2026, 22:39Managing Thrombotic Risk in Pregnancy – How the Lab May Help – Sysmex Europe
-
Oct 6, 2026, 22:33Ahmet Davut Aksu: A Multi-Objective Approach to Enhance Fibrinolysis, Selectivity, and Inhibition Resistance
-
Oct 6, 2026, 22:29Muhammad Abubakar: New Study on Iron Biology to Be Presented at ASH 2026 and Published in Blood
-
Oct 6, 2026, 22:24David McIntosh: Calling On Decision-Makers to Prioritize Donors and Clinical Access During IPAW 2026
-
Oct 6, 2026, 22:21Zoltan Nagy: With All Eyes on Optogenetics Today, What Can It Do in Megakaryocytes and Platelets?